Efficacy and safety of a flexible extended regimen of ethinylestradiol/drospirenone for the treatment of dysmenorrhea: a multicenter, randomized, open-label, active-controlled study

BACKGROUND: Dysmenorrhea is a common condition in women, which is characterized by menstrual pain. Low-dose estrogen/progestin combined oral contraceptives have been shown to reduce the severity of dysmenorrhea symptoms, and a 28-day cyclic regimen of ethinylestradiol/drospirenone (28d regimen) is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Momoeda, Mikio, Kondo, Masami, Elliesen, Joerg, Yasuda, Masanobu, Yamamoto, Shigetomo, Harada, Tasuku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422539/
https://www.ncbi.nlm.nih.gov/pubmed/28496369
http://dx.doi.org/10.2147/IJWH.S134576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422539/
https://www.ncbi.nlm.nih.gov/pubmed/28496369
http://dx.doi.org/10.2147/IJWH.S134576

Ejemplares similares